Jump to Navigation

Facebook Connect

User login

NLA Meetings

This information is still being developed by our faculty and will be posted here when available.

Meeting Info

This information is still being developed by our faculty and will be posted here when available.

Friday, February 27, 2015

Session I- Understanding the Impact of Public Policy in Healthcare

3:45 - 4:00 PM Chapter Presidents Welcome & Introduction Paul D. Rosenblit, MD & Kris Vijay, MD
4:00 - 4:30 PM Keynote Address – Detect.Connect.Control. Preventing a Million Together

Janet S. Wright, MD

4:30 - 5:00 PM Clinical Impacts of Cardiovascular Prevention Policy: A Lipidologist’s Perspective

Thomas A. Pearson, MD, PhD, MPH, FNLA

5:00 - 5:30 PM CVD Prevention: Integrated Health System Perspective

Ronald D. Scott, MD

5:30 - 6:00 PM Q&A Panel
6:00 - 7:00 PM Welcome Reception in Exhibit Hall

Saturday, February 28, 2015

Session II- Controversies in Clinical Lipid Management

7:00 - 8:00 AM Breakfast in Exhibit Hall
8:00 - 8:25 AM ACC/AHA CVD Prevention Guidelines Understanding Risk Assessment & Reduction

David C. Goff, Jr., MD, PhD

8:25 - 8:50 AM NLA Recommendations for Patient-Centered Management of Dyslipidemia

Matthew K. Ito, PharmD, FNLA

8:50 - 9:20 AM Two Different Prevention Approaches Two Different Perspectives

Carl E. Orringer, MD, FNLA

9:20 - 9:40 AM Next Steps in Lipid Management: An Expert Panel Discussion
9:40 - 10:00 AM Q&A Panel
10:00 - 10:30 AM Break in Exhibit Hall

Session III- Evolving Strategies and Targets for LDL-C and Non-HDL

10:30 - 11:00 AM Understanding the Molecular Biology of Atherosclerosis: The Future of Prevention and Intervention in Heart Disease

Paul N. Hopkins, MD, MSPH

11:00 - 11:30 AM Inflammation, Risk Prediction, and the Prevention of ASCVD

Paul M. Ridker, MD

11:30 - 12:00 Understanding the Effects of Lipid-lowering Therapy: MRI Studies of Carotid Atherosclerotic Plaques

Xue-Qiao Zhao, MD

12:00 - 12:30 PM Q&A Panel
12:30 - 12:45 PM NLA News & Notes
12:45 - 1:45 PM Lunch in Exhibit Hall

Session IV- Treatment Strategies for Hypertriglyceridemia

1:45 - 2:15 PM The Apolipoprotein C-III Story: Epidemiology, Metabolism, and Basic Science Lead to Treatment

Frank M. Sacks, MD

2:15 - 2:45 PM Absence of Clinical Outcome Trials Treating Moderate or Severe Hypertriglyceridemia: What is a Clinician to Do?

Terry A. Jacobson, MD, FNLA

2:45 - 3:15 PM Clinical Management of Hypertriglyceridemia: State of the Art 2015

Eliot A. Brinton, MD, FNLA

3:15 - 3:45 PM Q&A Panel
3:45 - 4:00 PM Break

Session V- Controversies in Lifestyle Management

4:00 - 4:30 PM The Role of Nutraceutical Supplements in the Treatment of Dyslipidemia and Dyslipidemia-induced Vascular Disease

Mark C. Houston, MD, MS, MSc

4:30 - 5:00 PM Popular Weight Loss Diet Fads and Obesity Guidelines: Is there an Ideal Diet for Weight Reduction?

Geeta Sikand, RD, MA, FNLA

5:00 - 5:30 PM EXERCISE PLEIOTROPHY: Just Move and Move Often

Ralph La Forge, MSc, FNLA

5:30 - 6:00 PM Q&A Panel
6:30 - 9:30 PM FNLA Event

Sunday, March 1, 2015

Session VI-Lipoprotein Particles versus Atherogenic Cholesterol: Which is a Better Target for Atherosclerosis Prevention

8:00 - 8:50 AM Breakfast
9:00 - 9:30 AM ApoB in Risk Assessment and the Diagnosis and Treatment of the Atherogenic Dyslipoproteinemias

Allan D. Sniderman, MD

9:30 - 10:00 AM New Targets and Treatments: Understanding LDL- P, Non- HDL-C , and ApoB

Samia Mora, MD

10:00 - 10:30 AM HDL-C, HDL-P, HDL Function in Relation to Risk Prediction & Treatment

Rachel H. Mackey, PhD, MPH

10:30 - 11:00 AM Q&A Panel
11:00 - AM Adjourn

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

This information is still being developed by our faculty and will be posted here when available.

2015 SATELLITE SYMPOSIA GUIDELINES

The National Lipid Association (NLA) has established that independently developed and CME/CE certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members. In this regard, we are pleased to offer satellite symposia slots in conjunction with our 2015 Clinical Lipid Updates.

Satellite symposia address educational needs and performance gaps that complement the NLA scientific program agenda. They may include one or a number of speakers and may cover one or several topics addressing the educational gaps of lipid specialists.

The following deadlines and guidelines provide important information about holding a Satellite Symposium at the 2015 Clinical Lipid Updates and the process for completing a symposium proposal. Please contact the NLA business development department directly (contact below) should there be any questions or further information required. See you in 2015!

DOWNLOAD 2015 SATELLITE SYMPOSIA GUIDELINES 2015

Contact:
Amina Resheidat
Program Coordinator
904-309-6212

aresheidat@lipid.org

0
No votes yet

Coming Soon...

0
No votes yet

This form is for submitting questions you may expect to have for presenters on the various topics offered through out the NLA's 2015 Annual Scientific Session. Please provide your name, select the talk for which your questions applies and provide a brief synopsis of your question. For reasons of time, we cannot guarantee that every speaker will be able to answer every question submitted to the.



by Dr. Radut.